(crédito: Anadolu Agency/Reprodução)

Ministry of Health confirms two cases of monkeypox in babies

posted on 08/24/2022 06:00


(credit: Anadolu Agency/Reproduction)

The Ministry of Health confirmed, yesterday, the first two cases of monkeypox (monkeypox) in babies. One of the records was a 10-month-old child, who lives in São Paulo, a state considered the epicenter of the disease, with 2,528 confirmed and 1,243 suspected, according to the ministry. The second was a two-month-old baby in Conceição do Jacuípe, 100km from Salvador.

In the world, Brazil is the third country in number of monkeypox occurrences. Until Monday, according to the latest epidemiological bulletin of the disease monitored by the ministry, there are 3,896 confirmed cases and 4,155 suspected cases – which indicates underreporting of the disease’s incidence. So far, 34 children between the ages of 0 and 9 have contracted the monkeypox virus in the country. Attention to the child age group is greater due to the fact that the immune system not yet fully developed can lead to the aggravation of the disease.

In this context, the National Health Surveillance Agency (Anvisa) received, yesterday, the request for analysis of the vaccine that will be imported by the Ministry of Health, via the Pan American Health Organization (PAHO), from the Danish laboratory Bavarian Nordic. The forecast is that three shipments of the immunizing agent will arrive, totaling 50,000 doses, as announced by Minister Marcelo Queiroga.

At Anvisa, which released the registration requirement, the government’s request will be evaluated by the Monkeypox Emergency Technical Commission, created by the regulatory agency to speed up the necessary acts in relation to the disease. The concentration, pharmaceutical formula, indications and contraindications, dosage, target population, route of administration and mode of use, among other information, will be verified.

In addition, international authorizations will be compared with the regulatory guidelines established in the Resolution of the Collegiate Board of Directors, which recognizes registrations issued abroad by related regulatory agencies. Only after these steps will the agency’s board of directors be able to approve the acquisition of smallpox vaccines.

However, Queiroga has already warned that the imported doses will not be enough to “control the outbreak of the disease”. The immunizers will be directed only to health professionals who have direct contact with the infected.

Unicamp

By the end of September, the High Performance Molecular Diagnosis Laboratory at the State University of Campinas (Unicamp) will be able to diagnose monkeypox. The laboratory will have two machines that, upon receiving blood samples from patients with symptoms of the disease, can deliver the result within eight hours. The exam will be of the PCR type. The exams will be carried out via the Unified Health System (SUS) and will serve the university’s own community.

Unicamp’s Hospital das Clínicas is a reference in the treatment of monkeypox and acts as a partner institution of the Adolfo Lutz Institute, one of the laboratories that are authorized to diagnose the disease in the country.

Unicamp created five fronts to fight smallpox — diagnosis, clinical research, epidemiological surveillance, basic research and communication. All these activities will be integrated into the task force being implemented at the university.

#Ministry #Health #confirms #cases #monkeypox #babies

Leave a Comment

Your email address will not be published.